Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study-Reference-Cited by-同舟云学术

Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study

Published:2010-03-29 Issue:7 Volume:25 Page:896-905
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Eggert Karla,Squillacote David,Barone Paolo,Dodel Richard,Katzenschlager Regina,Emre Murat,Lees Andrew J.,Rascol Olivier,Poewe Werner,Tolosa Eduardo,Trenkwalder Claudia,Onofrj Marco,Stocchi Fabrizio,Nappi Giuseppe,Kostic Vladimir,Potic Jagoda,Ruzicka Evzen,Oertel Wolfgang,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference27 articles.

1. Levodopa and the progression of Parkinson's disease;Fahn;N Engl J Med,2004

2. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology;Miyasaki;Neurology,2002

3. Present and future drug treatment for Parkinson's disease;Schapira;J Neurol Neurosurg Psychiatry,2005

4. Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients;Blanchet;Can J Neurol Sci,1996

5. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease;Deane;Cochrane Database Syst Rev,2004

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data;eClinicalMedicine;2024-08

2. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

3. Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors;Frontiers in Cell and Developmental Biology;2023-10-24

4. The safety of perampanel in different disorders and doses: A meta-analysis;Seizure;2023-03

5. Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective;International Journal of Molecular Sciences;2023-01-18